Incidence of gastrointestinal disease that may significantly alter the absorption of ACY 241.
Gastrointestinal disease
Incidence of gastrointestinal disease that may significantly alter the absorption of ACY 241.
Incidence of gastrointestinal disease that may significantly alter the absorption of lenalidomide
Use of medications that alter the absorption or metabolism of levothyroxine
Not be on agents known to alter rapamycin metabolism significantly
On agents known to alter rapamycin metabolism significantly
Patient must be able to take oral medications; patients may not have any impairment of gastrointestinal function or gastrointestinal disease that may significantly alter the absorption of the study drug
Incidence of gastrointestinal disease that may significantly alter the absorption of lenalidomide
Patient must be able to take oral medications; patients may not have any impairment of gastrointestinal function or gastrointestinal disease that may significantly alter the absorption of the study drug
Subject has incidence of gastrointestinal disease that may significantly alter the absorption of LEN
Patients with impairment of gastrointestinal function that may alter the absorption of BKM120
Impairment of gastrointestinal function
Impairment of gastrointestinal function
Impairment of gastrointestinal function
Patients with impairment of gastrointestinal function or disease
History of gastrointestinal disease
Impairment of gastrointestinal function or gastrointestinal disease that may alter the absorption of sunitinib.
Gastrointestinal Function
Known impairment of gastrointestinal function that would alter drug absorption.
Impairment of gastrointestinal function/disease that may significantly alter the absorption of everolimus.
Incidence of gastrointestinal disease that may significantly alter the absorption of pomalidomide
